SYMCEL
Apply for demo
  • calScreener™
    • Product Suite
    • Technology
  • Applications
    • Microbiology
      • Biofilm
      • Clinical Applications
      • Complex Models
      • Fungi
      • Antimicrobials Development
    • Probiotics & Microbiome
    • Thermogenesis
    • Cancer Biology
    • Horizon 2020
  • Learning Center
    • Publications
    • Testimonials
    • Science Blog
    • Data analysis tool
  • News
  • About Us
    • Team
    • Board
    • Scientific Advisors
    • Careers
  • Contact
    • General Inquiries
    • Service & Support
  • calScreener™
    • Product Suite
    • Technology
  • Applications
    • Microbiology
      • Biofilm
      • Clinical Applications
      • Complex Models
      • Fungi
      • Antimicrobials Development
    • Probiotics & Microbiome
    • Thermogenesis
    • Cancer Biology
    • Horizon 2020
  • Learning Center
    • Publications
    • Testimonials
    • Science Blog
    • Data analysis tool
  • News
  • About Us
    • Team
    • Board
    • Scientific Advisors
    • Careers
  • Contact
    • General Inquiries
    • Service & Support
Symcel raises 105 MSEK to develop rapid diagnostics to combat severe infections
10 Mar
Symcel raises 105 MSEK to develop rapid diagnostics to combat severe infections

– The funding will also accelerate the commercialization of Symcel’s R&D product offering (STOCKHOLM) Symcel — a company providing real-time metabolic measurements of living organisms with their analytical instrument the calScreener™  ̶  today...

NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis
29 Nov
NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis

– New antibiotic potentiating activity has been discovered for treatment of Cystic Fibrosis associate infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for bacteria and cell culture with their product the...

One step closer to a pill for weight loss without diet or exercise
21 Sep
One step closer to a pill for weight loss without diet or exercise

– A new screening method will help to discover drugs that force the body to burn fat reserves. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently involved in...

NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model
7 Sep
NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model

– Metabolic readouts highlighted which treatment parameters were most effective. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently involved in a...

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis
31 May
Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis

(STOCKHOLM) Symcel — a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently featured in a peer-reviewed publication showing that metastatic potential of certain tumours is related...

NEW PUBLICATION: Metabolism measurements reveal insights into antimicrobial resistance
4 May
NEW PUBLICATION: Metabolism measurements reveal insights into antimicrobial resistance

(STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™  ̶  was recently featured in a peer-reviewed publication showing how metabolic data shed new light on the evolution of...

Symcel calScreener™ real-time metabolic analysis predicts how well antibiotics will work in-vivo
14 Jan
Symcel calScreener™ real-time metabolic analysis predicts how well antibiotics will work in-vivo

– New data suggest old antibiotics used in new combinations can be effective against drug resistant infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™  ̶  was...

CEO update on COVID-19
3 Apr
CEO update on COVID-19

We find ourselves in the middle of a global pandemic that is causing a great deal of uncertainty from international governments to individual families. With that in mind, I want Symcel’s position to be clear throughout and we will be posting regular...

Taking advantage of our online systems during the COVID-19 Pandemic
19 Mar
Taking advantage of our online systems during the COVID-19 Pandemic

COVID-19 is forcing everyone to reconsider how they work. At Symcel, while we place a lot of value on personal interactions, we also have strong digital workflows that allow us to do our jobs remotely. These workflows have prepared us for the...

New publication: microcalorimetry provides robust antimicrobial susceptibility test
5 Feb
New publication: microcalorimetry provides robust antimicrobial susceptibility test

The first publication from Symcel’s European H2020 project was published at the end of January. The project named BADGER (Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time) focuses on clinical validation for new...

  • 1 2
SYMCEL
info@symcel.com

Tomtebodavägen 6, 171 65, Stockholm, Sweden